ED
CBAY

Exane Derivatives’s Cymabay Therapeutics CBAY Stock Holding History

Exane Derivatives’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-36,133
Closed -$132K – 1089
2021
Q3 		$132K Buy
36,133
+1,919
+6% +$7K 0.03% 478
2021
Q2 		$146K Buy
+34,214
New +$146K 0.03% 476